Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991 Jan 15;273(Pt 2)(Pt 2):271-5.
doi: 10.1042/bj2730271.

Control and function of the transamination pathways of glutamine oxidation in tumour cells

Affiliations
Comparative Study

Control and function of the transamination pathways of glutamine oxidation in tumour cells

Z Kovacević et al. Biochem J. .

Abstract

Parallel investigations of the transamination pathways of glutamine oxidation in Ehrlich ascites carcinoma (EAC) and AS 30D hepatoma revealed that hepatoma cells, unlike EAC, produce very little aspartate. This cannot be explained by differences in the activity of glutamine-metabolizing enzymes. Also, the mitochondria from the hepatoma respired at a similar rate to EAC mitochondria with glutamine as sole substrate producing substantial amounts of aspartate. Unlike their isolated mitochondria, intact hepatoma cells showed a very low rate of glutamine oxidation. Compared with EAC, the rate of L-[U-14C]glutamine consumption by AS 30D hepatoma cells was much lower, with insignificant production of 14C-labelled aspartate and CO2. This suggested that the glutamine-transporting system in the hepatoma cell plasma membrane had a very low activity. Isolated hepatoma mitochondria produced 3 times more pyruvate from malate than did EAC mitochondria, indicating a higher activity of NAD(P)-dependent malic enzyme. We postulate that an active malic enzyme may suppress the synthesis of aspartate in hepatoma cells, but further evidence is needed to confirm this assumption.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem J. 1988 Jun 1;252(2):381-6 - PubMed
    1. Biochem J. 1988 Jan 15;249(2):443-9 - PubMed
    1. Cancer Res. 1970 Sep;30(9):2306-9 - PubMed
    1. Cancer Res. 1972 Feb;32(2):326-33 - PubMed
    1. Biochem J. 1971 Dec;125(3):757-63 - PubMed

Publication types

MeSH terms

Grants and funding